Apellis Pharmaceuticals (APLS) Other Gross PP&E Adjustments (2020 - 2025)
Apellis Pharmaceuticals (APLS) has 6 years of Other Gross PP&E Adjustments data on record, last reported at -$62.2 million in Q4 2025.
- For Q4 2025, Other Gross PP&E Adjustments fell 13.9% year-over-year to -$62.2 million; the TTM value through Dec 2025 reached -$62.2 million, down 13.9%, while the annual FY2025 figure was -$62.2 million, 13.9% down from the prior year.
- Other Gross PP&E Adjustments reached -$62.2 million in Q4 2025 per APLS's latest filing, down from -$19.7 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at -$14.6 million in Q2 2025 and bottomed at -$62.2 million in Q4 2025.
- Average Other Gross PP&E Adjustments over 5 years is -$26.5 million, with a median of -$19.8 million recorded in 2022.
- Peak YoY movement for Other Gross PP&E Adjustments: tumbled 69.3% in 2021, then grew 20.68% in 2023.
- A 5-year view of Other Gross PP&E Adjustments shows it stood at -$42.3 million in 2021, then decreased by 14.45% to -$48.4 million in 2022, then dropped by 0.08% to -$48.5 million in 2023, then fell by 12.63% to -$54.6 million in 2024, then fell by 13.9% to -$62.2 million in 2025.
- Per Business Quant database, its latest 3 readings for Other Gross PP&E Adjustments were -$62.2 million in Q4 2025, -$19.7 million in Q3 2025, and -$14.6 million in Q2 2025.